Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 6
2018 3
2019 5
2020 3
2021 6
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives.
Ramadan WS, Saber-Ayad MM, Saleh E, Abdu-Allah HHM, El-Shorbagi AA, Menon V, Tarazi H, Semreen MH, Soares NC, Hafezi S, Venkatakhalam T, Ahmed S, Kanie O, Hamoudi R, El-Awady R. Ramadan WS, et al. Among authors: tarazi h. iScience. 2023 Dec 9;27(1):108659. doi: 10.1016/j.isci.2023.108659. eCollection 2024 Jan 19. iScience. 2023. PMID: 38235331 Free PMC article.
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19.
Hersi F, Sebastian A, Tarazi H, Srinivasulu V, Mostafa A, Allayeh AK, Zeng C, Hachim IY, Liu SL, Abu-Yousef IA, Majdalawieh AF, Zaher DM, Omar HA, Al-Tel TH. Hersi F, et al. Among authors: tarazi h. Eur J Med Chem. 2023 Jun 5;254:115380. doi: 10.1016/j.ejmech.2023.115380. Epub 2023 Apr 17. Eur J Med Chem. 2023. PMID: 37075625 Free PMC article.
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.
Abu Rabah RR, Sebastian A, Vunnam S, Sultan S, Tarazi H, Anbar HS, Shehata MK, Zaraei SO, Elgendy SM, Al Shamma SA, Omar HA, Al-Tel TH, El-Gamal MI. Abu Rabah RR, et al. Among authors: tarazi h. Bioorg Med Chem. 2022 Sep 1;69:116894. doi: 10.1016/j.bmc.2022.116894. Epub 2022 Jun 20. Bioorg Med Chem. 2022. PMID: 35764033
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.
Zaraei SO, Al-Ach NN, Anbar HS, El-Gamal R, Tarazi H, Tokatly RT, Kalla RR, Munther MA, Wahba MM, Alshihabi AM, Shehata MK, Sbenati RM, Shahin AI, El-Awady R, Al-Tel TH, El-Gamal MI. Zaraei SO, et al. Among authors: tarazi h. Eur J Med Chem. 2022 Aug 5;238:114434. doi: 10.1016/j.ejmech.2022.114434. Epub 2022 May 5. Eur J Med Chem. 2022. PMID: 35551038
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.
El-Gamal MI, Mewafi NH, Abdelmotteleb NE, Emara MA, Tarazi H, Sbenati RM, Madkour MM, Zaraei SO, Shahin AI, Anbar HS. El-Gamal MI, et al. Among authors: tarazi h. Molecules. 2021 Dec 5;26(23):7376. doi: 10.3390/molecules26237376. Molecules. 2021. PMID: 34885957 Free PMC article. Review.
Current Status of Baricitinib as a Repurposed Therapy for COVID-19.
Saber-Ayad M, Hammoudeh S, Abu-Gharbieh E, Hamoudi R, Tarazi H, Al-Tel TH, Hamid Q. Saber-Ayad M, et al. Among authors: tarazi h. Pharmaceuticals (Basel). 2021 Jul 15;14(7):680. doi: 10.3390/ph14070680. Pharmaceuticals (Basel). 2021. PMID: 34358107 Free PMC article. Review.
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM, Zaraei SO, El-Gamal MI, Anbar HS, Tarazi H, Zoghbor MM, Mohamood NA, Khakpour MM, Zaher DM, Omar HA, Alach NN, Shehata MK, El-Gamal R. Sbenati RM, et al. Among authors: tarazi h. Eur J Med Chem. 2021 Jan 15;210:113081. doi: 10.1016/j.ejmech.2020.113081. Epub 2020 Dec 4. Eur J Med Chem. 2021. PMID: 33310290
27 results